semaglutide vs tirzepatide doses TrimRX Semaglutide vs Tirzepatide: Weight Loss,

How does Retatrutide compare to Ozempic or Wegovy

Spherical Insights has segmented the South Africa diabetes drugs market based on the below-mentioned segments: South Africa Diabetes Drugs Market, By Drug Class Insulin DPP-4 inhibitors SGLT2 inhibitors GLP-1 receptor agonists Others South Africa Diabetes Drugs Market, By Diabetes Type Type-1 Diabetes Type-2 Diabetes South Africa Diabetes Drugs Market, By Route of Administration Oral Subcutaneous Intravenous Need help to buy this report?

What Are The Side Effects of GLP-1 Medications GLP-1 medications are generally well tolerated

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)

LL-C: Writing original draft

Mounjaro puede contribuir a un mayor riesgo de tumores de clulas C de la tiroides, pancreatitis aguda, enfermedad de la vescula biliar, hipoglucemia, lesin renal aguda, efectos secundarios gastrointestinales graves, reacciones de hipersensibilidad y empeoramiento de la retinopata diabtica si padece diabetes tipo 2